Comparative safety analysis of antiinterleukin-4/interleukin-13 inhibitors and Janus Kinase inhibitors in atopic dermatitis

被引：1
|
作者：
Bao, Aaron [1 ]
Su, Hsing-Jou [1 ]
Wan, Joy [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Dermatol, 200 N Wolfe St,Suite 2107, Baltimore, MD 21287 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2024年 / 91卷 / 04期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/j.jaad.2024.06.064
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：768 / 771
页数：4
相关论文
共 50 条
  • [41] Short-term efficacy and safety of biologics and Janus kinase inhibitors for patients with atopic dermatitis: A systematic review and meta-analysis
    Chen, Qianyu
    Cui, Lian
    Chen, Zeyu
    Gao, Yunlu
    Shi, Yuling
    HELIYON, 2023, 9 (11)
  • [42] Application of Janus Kinase Inhibitors in Atopic Dermatitis: An Updated Systematic Review and Meta-Analysis of Clinical Trials
    Tsai, Hou-Ren
    Lu, Jing-Wun
    Chen, Li-Yu
    Chen, Tai-Li
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (04):
  • [43] Janus kinase inhibitors for the treatment of atopic dermatitis-evaluation of current data and practical experience
    Lauffer, Felix
    Biedermann, Tilo
    DERMATOLOGIE, 2022, 73 (07): : 520 - 528
  • [44] Dose flexibility of oral Janus kinase inhibitors for long-term control of atopic dermatitis
    Ebata, Toshiya
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (02) : 165 - 165
  • [45] Efficacy and Risk Stratification of Janus Kinase Inhibitors in the Treatment of Moderate-to-Severe Atopic Dermatitis
    Narla, Shanthi
    Silverberg, Jonathan I.
    DERMATITIS, 2024, 35 : S24 - S38
  • [46] Janus Kinase Inhibitors in Dermatology: Part 2: Applications in Psoriasis, Atopic Dermatitis, and Other Dermatoses
    Garcia-Melendo, C.
    Cubiro, X.
    Puig, L.
    ACTAS DERMO-SIFILIOGRAFICAS, 2021, 112 (07): : 586 - 600
  • [47] Effects of phosphodiesterase inhibitors on interleukin-4 and interleukin-13 generation from human basophils
    Eskandari, N
    Wickramasinghe, T
    Peachell, PT
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 142 (08) : 1265 - 1272
  • [48] The efficacy and safety of IL-13 inhibitors in atopic dermatitis: A systematic review and meta-analysis
    Zhang, Yan
    Jing, Danrong
    Cheng, Jun
    Chen, Xiang
    Shen, Minxue
    Liu, Hong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [49] Association analysis of non-synonymous polymorphisms of interleukin-4 receptor-α and interleukin-13 genes in canine atopic dermatitis
    Tanaka, Kazuaki
    Yamamoto-Fukuda, Misaki
    Takizawa, Tatsuya
    Shimakura, Hidekatsu
    Sakaguchi, Masahiro
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2020, 82 (09): : 1253 - 1259
  • [50] Enhanced expression levels of interleukin-31 correlate with interleukin-4 and interleukin-13 in atopic and allergic contact dermatitis
    Neis, M. M.
    Peters, B.
    Dreuw, A.
    Bieber, T.
    Krieg, T.
    Stanzel, S.
    Heinrich, P. C.
    Merk, H. F.
    Baron, J. M.
    Hermanns, H. M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 59 - 59
12345